Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

Swiss ministers have met with senior executives of pharmaceutical companies Roche and Novartis to discuss the outlook for the ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

Learn more about whether Amneal Pharmaceuticals, Inc. or Liquidia Corporation is a better investment based on AAII's A+ ...

The Q2 pharma earnings season featured changes in the obesity race as well as insights into drugmakers’ views on tariffs and drug pricing.

Swiss ministers met with senior executives from Roche and Novartis to discuss the potential impact of U.S. import tariffs on pharmaceuticals. While pharmaceuticals currently avoid these tariffs, an ...

No additional tariffs have been imposed on Indian exports to the United States in key sectors such as pharmaceuticals and ...

This capability makes the TBSend Card a versatile tool that can support a wide range of diagnostic needs in TB management.

OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.